Company profile

David A. Ricks
Incorporated in
Fiscal year end
Former names
Lilly Eli & Co, Lilly Eli & Co Et Al
IRS number

LLY stock data

FINRA relative short interest over last month (20 trading days) ?


19 Feb 20
25 Feb 20
31 Dec 20


Company financial data Financial data

Quarter (USD) Dec 19 Sep 19 Jun 19 Mar 19
Revenue 6.11B 5.48B 5.64B 5.09B
Net income 1.5B 1.25B 1.33B 4.24B
Diluted EPS 1.64 1.37 1.44 4.31
Net profit margin 24.46% 22.90% 23.55% 83.30%
Net change in cash 253.8M -5.28B
Cash on hand 2.34B 2.29B 2.04B
Cost of revenue 1.28B 1.18B 1.12B 1.14B
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue 22.32B 21.49B 19.97B 21.22B
Net income 8.32B 3.23B -204.1M 2.74B
Diluted EPS 8.89 3.13 -0.19 2.58
Net profit margin 37.27% 15.04% -1.02% 12.90%
Net change in cash -4.98B 784.5M 1.95B 915.7M
Cash on hand 2.34B 7.32B 6.54B 4.58B
Cost of revenue 4.72B 4.68B 4.45B 5.71B

Financial data from company earnings reports

76.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1602 1490 +7.5%
Opened positions 214 98 +118.4%
Closed positions 102 85 +20.0%
Increased positions 505 492 +2.6%
Reduced positions 567 613 -7.5%
13F shares
Current Prev Q Change
Total value 994.02B 833.48B +19.3%
Total shares 735.4M 734.41M +0.1%
Total puts 4.79M 3.47M +38.4%
Total calls 4.04M 3.26M +24.1%
Total put/call ratio 1.2 1.1 +11.5%
Largest owners
Shares Value Change
Lilly Endowment 114.56M $15.06B -1.7%
Vanguard 70.92M $9.32B -0.1%
BLK BlackRock 60.88M $8B -0.4%
Wellington Management 44.35M $5.83B +11.8%
Primecap Management 43.12M $5.67B +0.7%
STT State Street 37.17M $4.88B +0.2%
Capital International Investors 26.06M $3.42B +3.6%
JPM JPMorgan Chase & Co. 18.64M $2.45B +19.9%
State Farm Mutual Automobile Insurance 18.62M $2.45B -6.6%
FMR 14.24M $1.87B +6.7%
Largest transactions
Shares Bought/sold Change
Wellington Management 44.35M +4.68M +11.8%
Jennison Associates 4.51M +3.16M +233.0%
JPM JPMorgan Chase & Co. 18.64M +3.09M +19.9%
Nuveen Asset Management 4.12M -2.74M -39.9%
Lilly Endowment 114.56M -2.04M -1.7%
State Farm Mutual Automobile Insurance 18.62M -1.32M -6.6%
Investec Asset Management 37.59K -1.32M -97.2%
Alliancebernstein 3.76M -1.16M -23.5%
Arrowstreet Capital, Limited Partnership 117.4K -1.07M -90.2%
Carmignac Gestion 0 -1.01M EXIT
Content analysis ?
H.S. freshman Avg
New words: addressing, adenocarcinoma, affinity, aforementioned, analyst, analytical, ankylosing, Asymptomatic, attend, autoinjector, axillary, Baqsimi, bind, BTK, caption, Centrexion, cloth, Colorado, Commonwealth, communicated, communicating, communication, conciliation, conclusion, confer, constitutionality, contrary, County, Crohn, deceptive, degradation, deposit, dermatology, Dermira, DIAD, dialogue, Divisional, doctrine, dominantly, draft, easier, Eddingpharm, EGFR, EMA, exceed, expiry, fall, frequently, FWK, glycopyrronium, Hakim, harbor, hepatocellular, immovable, ImmuNext, implicit, incorrect, inherited, inquired, interchangeable, Internet, IP, junction, Kentucky, knowledge, Lastly, lebrikizumab, literal, literally, manipulation, Mason, matter, maximizer, media, modernized, NaN, obesity, Optum, pandemic, passage, passed, PGR, Pharmachem, post, prepaid, Prime, print, Qbrexza, radio, rearranged, reconciling, reexamine, rehearing, rent, resiliency, Reyvow, sample, Saskatchewan, Scientific, selpercatinib, somatostatin, specialist, specialty, strike, subpoena, Suzhou, sweating, telephonic, television, Tokyo, transfection, Trijardy, TSA, uncontrolled, unlimited, unsuccessful, Vermont, Vitrakvi, Weiler, Wellcare, wholly, withdrawal, withdrawing, writ
Removed: Abemaciclib, abundant, additive, Adocia, agricultural, Agriculture, AH, Amyvid, angioplasty, anticoccidial, APP, appealing, apply, atherectomy, attempting, baricitinib, benchmark, BMS, bordetella, bulimia, bulk, Cadillac, canine, cattle, century, chewable, Clinton, closure, Coban, cognitive, combining, commenced, companion, comparability, Complementaria, conditional, conditionally, consume, consumption, Conterno, coronary, Daiichi, de, Denagard, depressed, deteriorating, deterioration, DICOM, disagree, discontinuing, Divisa, division, Duramune, economy, ehf, empagliflozin, Enrique, enteric, EU, Euronext, Evista, excise, exclusive, exclusively, expressing, extraordinary, farm, feed, feline, field, fiscal, flea, focused, Gemzar, German, happier, Harrington, healthier, heartworm, Hexal, humanity, hydrochloride, Idec, identifying, inclusion, intervention, intestinal, invasive, investigating, KGaA, language, leasing, limiting, linagliptin, live, livestock, Lyme, mania, Maxiban, metformin, mission, modification, Monteban, monthly, nervosa, neuritic, Olaratumab, Optaflexx, outbreak, ovarian, panic, parasite, Parenteral, participant, Paylean, planned, Portrazza, poultry, pretax, processing, promoting, prospectively, Prozac, radioactive, recognizing, reconsider, recurrent, regulate, representative, requesting, respiratory, retrospectively, revolving, Rumensin, Russia, salespeople, salt, Sankyo, sarcoma, selective, Sherman, SICAD, situation, soft, software, stent, strongly, sundry, swine, syndrome, tablet, thrombotic, tissue, translate, Trump, Tylan, ultra, undergoing, Union, unpatentable, user, vaccine, Venezuela, Venezuelan, veterinary, Vetmedica, vision